99 related articles for article (PubMed ID: 2169779)
1. A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group.
Soukop M
Eur J Cancer; 1990; 26 Suppl 1():S15-9. PubMed ID: 2169779
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. The Granisetron Study Group.
Smith IE
Eur J Cancer; 1990; 26 Suppl 1():S19-23. PubMed ID: 2169780
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis.
Cupissol DR; Serrou B; Caubel M
Eur J Cancer; 1990; 26 Suppl 1():S23-7. PubMed ID: 2169782
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group.
Chevallier B
Eur J Cancer; 1990; 26 Suppl 1():S33-6. PubMed ID: 2169784
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of two doses of granisetron in the treatment of chemotherapy-induced emesis. Dutch results within a multinational study.
Bots MW; Dijkstra HJ; Blijham GH; van der Wall E; Fehmers MC; Keizer HJ; Nortier JW; Siegenbeek van Heukelom L; Slee PH; Veenhof CH
Neth J Med; 1992 Jun; 40(5-6):221-6. PubMed ID: 1331830
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group.
Marty M
Eur J Cancer; 1990; 26 Suppl 1():S28-32. PubMed ID: 2169783
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the antiemetic effectiveness of granisetron and alizapride plus dexamethasone in cytostatic therapy].
Bremer K; Uhlenbusch R
Dtsch Med Wochenschr; 1991 Nov; 116(48):1817-23. PubMed ID: 1659980
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
[TBL] [Abstract][Full Text] [Related]
9. A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin. Granisetron Study Group.
Soukop M
Support Care Cancer; 1994 May; 2(3):177-83. PubMed ID: 8032704
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy.
Ettinger DS; Eisenberg PD; Fitts D; Friedman C; Wilson-Lynch K; Yocom K
Cancer; 1996 Jul; 78(1):144-51. PubMed ID: 8646710
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.
Audhuy B; Cappelaere P; Martin M; Cervantes A; Fabbro M; Rivière A; Khayat D; Bleiberg H; Faraldi M; Claverie N; Aranda E; Auclerc G; Audhuy B; Benhammouda A; Bleiberg H; Cals L; Cappelaere P; Cattan A; Cervantes A; Chevallier B; Conroy T; Cupissol D; De Grève J; Diaz-Rubio E; Seitz JF
Eur J Cancer; 1996 May; 32A(5):807-13. PubMed ID: 9081358
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
[TBL] [Abstract][Full Text] [Related]
13. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
14. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
Cheirsilpa A; Sinthusake T; Songsakkaesorn A; Visawaprasit S; Chulaka K; Changkuingdee N
Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin.
Navari RM; Kaplan HG; Gralla RJ; Grunberg SM; Palmer R; Fitts D
J Clin Oncol; 1994 Oct; 12(10):2204-10. PubMed ID: 7931490
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--multi-centered placebo-controlled double-blind comparative study].
Suminaga M; Furue H; Ohta K; Taguchi T; Niitani H; Ogawa N
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1211-9. PubMed ID: 8392826
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy].
Tsukuda M; Kokatsu T; Furukawa S; Kohno H; Kubota A; Furukawa M; Enomoto H
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2037-41. PubMed ID: 8215478
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of granisetron for nausea and vomiting induced by anticancer drugs--optimal dose-finding study].
Suminaga M; Furue H; Ohta K; Taguchi T; Niitani H; Ogawa N
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1203-10. PubMed ID: 8392825
[TBL] [Abstract][Full Text] [Related]
20. An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy.
Tabona MV
Eur J Cancer; 1990; 26 Suppl 1():S37-44. PubMed ID: 2169785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]